Takeda Pharmaceutical Co President and Chief Executive Officer Christophe Weber speaks during the Wall Street Journal CEO Conference in Tokyo, Japan May 15, 2018. REUTERS
ZURICH, Sept 23 (Reuters) – Roche on Wednesday said it was proposing Christoph Weber, the former CEO of Takeda Pharmaceuticals, for election to the Swiss company’s board of directors at its AGM next March.
“Christophe’s intimate knowledge of the healthcare industry and his broad leadership experience will further strengthen our Board,” said Roche Chairman Severin Schwan in a statement.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Reporting by John Revill Editing by Linda Pasquini
